Lu Chen

2.6k total citations · 1 hit paper
95 papers, 1.9k citations indexed

About

Lu Chen is a scholar working on Epidemiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Lu Chen has authored 95 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 20 papers in Molecular Biology and 19 papers in Cell Biology. Recurrent topics in Lu Chen's work include Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (8 papers). Lu Chen is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (8 papers). Lu Chen collaborates with scholars based in China, United States and Canada. Lu Chen's co-authors include David K Banfield, Linna Tu, William Tai, Jinlu Wu, En-De Hu, Lanman Xu, Da‐Zhi Chen, Feng‐Bin Lu, Chi Yang and Ming Dang and has published in prestigious journals such as Science, Gastroenterology and PLoS ONE.

In The Last Decade

Lu Chen

88 papers receiving 1.9k citations

Hit Papers

Injectable hydrogel with MSNs/microRNA-21-5p delivery ena... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Chen China 25 742 389 333 258 224 95 1.9k
Xing‐Hua Gao China 29 586 0.8× 480 1.2× 445 1.3× 256 1.0× 257 1.1× 197 3.1k
Kamil Can Akçalı Türkiye 23 912 1.2× 468 1.2× 293 0.9× 160 0.6× 255 1.1× 61 2.1k
Hong‐Duo Chen China 30 714 1.0× 719 1.8× 404 1.2× 199 0.8× 222 1.0× 204 3.3k
Young‐Joon Seo South Korea 30 693 0.9× 462 1.2× 359 1.1× 245 0.9× 226 1.0× 198 3.2k
Cheng‐Che E. Lan Taiwan 26 463 0.6× 383 1.0× 208 0.6× 166 0.6× 260 1.2× 89 2.5k
Yuesheng Huang China 27 964 1.3× 281 0.7× 582 1.7× 162 0.6× 117 0.5× 140 2.2k
Yidong Wang China 28 973 1.3× 250 0.6× 469 1.4× 242 0.9× 233 1.0× 73 2.4k
Kwang Hyun Cho South Korea 32 575 0.8× 674 1.7× 441 1.3× 257 1.0× 392 1.8× 134 3.5k
Yilin Wang China 21 639 0.9× 307 0.8× 178 0.5× 125 0.5× 160 0.7× 136 1.7k
Kang Liu China 25 1.3k 1.7× 214 0.6× 235 0.7× 229 0.9× 331 1.5× 89 2.3k

Countries citing papers authored by Lu Chen

Since Specialization
Citations

This map shows the geographic impact of Lu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Chen more than expected).

Fields of papers citing papers by Lu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Chen. The network helps show where Lu Chen may publish in the future.

Co-authorship network of co-authors of Lu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Chen. A scholar is included among the top collaborators of Lu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Chen. Lu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhuoya, Lu Chen, Shuo Zhang, et al.. (2025). The role of the peripheral immune system in mediating axonal dysfunction in early-stage amyotrophic lateral sclerosis: an age- and sex-based analysis. Neural Regeneration Research. 1 indexed citations
3.
Kong, Weibo, Guanghua Li, Zhuang Liu, et al.. (2024). ACADL-YAP axis activity in non-small cell lung cancer carcinogenicity. Cancer Cell International. 24(1). 86–86. 1 indexed citations
4.
Shang, Jackie, Kevin J. Coe, Hyun Kyoon Lim, et al.. (2024). Application of Covalent Binding Body Burden in the HμREL Human Hepatocyte Coculture Model for Reactivity Risk Assessment of Metabolically Low Turnover Drugs. Chemical Research in Toxicology. 37(4). 540–544. 1 indexed citations
5.
Chen, Lu, Yilin Huang, Congyi Zheng, et al.. (2024). Relation of Reproductive Lifespan with Obesity in Chinese Women: Results from a Large Representative Nationwide Population. Journal of Women s Health. 34(3). e392–e400. 1 indexed citations
6.
7.
Davis, John W., Susan C. Weller, Laura Porterfield, Lu Chen, & Gregg S. Wilkinson. (2023). Statin Use and the Risk of Venous Thromboembolism in Women Taking Hormone Therapy. JAMA Network Open. 6(12). e2348213–e2348213. 5 indexed citations
8.
Huang, Yan, Rongtao Lai, Weijing Wang, et al.. (2022). Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients. Frontiers in Cellular and Infection Microbiology. 11. 733348–733348. 14 indexed citations
10.
Murai, Yasuhisa, Ukhyun Jo, Junko Murai, et al.. (2021). SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243. Cancer Research. 81(11). 3067–3078. 33 indexed citations
11.
Chen, Lu, Wenguang Liu, Fei Xiong, et al.. (2021). 3D-QSAR, molecular docking and molecular dynamics simulations analyses of a series of heteroaryldihydropyrimidine derivatives as hepatitis B virus capsid assembly inhibitors. New Journal of Chemistry. 45(47). 22062–22076. 22 indexed citations
12.
Chen, Lu, Dongming Liu, Xianfu Yi, et al.. (2020). The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway. Cell Death and Disease. 11(5). 320–320. 32 indexed citations
13.
Chen, Lu, et al.. (2019). The Pharmacokinetic Prediction of Cyclosporin A after Coadministration with Wuzhi Capsule. AAPS PharmSciTech. 20(6). 247–247. 15 indexed citations
14.
Hu, En-De, Da‐Zhi Chen, Jinlu Wu, et al.. (2018). High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier. Cellular Immunology. 328. 24–32. 75 indexed citations
15.
Sun, Jingyuan, Vincent E. Groppi, Honglian Gui, et al.. (2015). High-Throughput Screening for Drugs that Modulate Intermediate Filament Proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 568. 163–185. 15 indexed citations
16.
Tu, Linna, Lu Chen, & David K Banfield. (2012). A Conserved N‐terminal Arginine‐Motif in GOLPH3‐Family Proteins Mediates Binding to Coatomer. Traffic. 13(11). 1496–1507. 49 indexed citations
17.
Li, Chuanfu, Fang Hua, Tuanzhu Ha, et al.. (2012). Activation of Myocardial Phosphoinositide-3-Kinase p110α Ameliorates Cardiac Dysfunction and Improves Survival in Polymicrobial Sepsis. PLoS ONE. 7(9). e44712–e44712. 21 indexed citations
18.
Wang, Jian, et al.. (2010). A comparative study of three prognostic systems for rebleeding in decompensated liver cirrhotic patients with esophageal varices. Zhonghua xiaohua zazhi. 30(6). 365–368. 1 indexed citations
19.
Wen, Wenyu, Lu Chen, Hao Wu, et al.. (2006). Identification of the Yeast R-SNARE Nyv1p as a Novel Longin Domain-containing Protein. Molecular Biology of the Cell. 17(10). 4282–4299. 39 indexed citations
20.
Chen, Lu. (1973). A COMPLEMENT FIXATION TEST FOR THE DETECTION OF ALPHA-FETO-PROTEIN IN THE DIAGNOSIS OF PRIMARY LIVER CANCER. 中国科学A辑(英文版).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026